Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality

Joint Authors

Sánchez Sánchez, Ernesto
González Baena, Antonio Carlos
González Cáliz, Carlos
Caballero Paredes, Fernando
Moyano Calvo, José Luis
Castiñeiras Fernández, Jesús

Source

Prostate Cancer

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-01-29

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Diseases
Medicine

Abstract EN

Objectives.

To estimate the prevalence of unsuspected anxiety or depression in prostate cancer patients and their spouses, as well as factors involved in its onset.

Materials and Methods.

A prospective study of 184 patients and 137 spouses evaluated in our hospital during 2019 using the Memorial Anxiety Scale for Prostate Cancer (MAX-PC), Hospital Anxiety and Depression Scale (HADS) and Patient Health Questionnaire depression module (PHQ-9).

This study provides an internal validity assessment of the scales and their correlation (alpha and rho coefficients; index r).

The contributions of age, education level, months after diagnosis, pain, prostate-specific antigen (PSA) level, stage of the disease and treatment performed to the positivity of the questionnaires were studied using the Wilcoxon–Mann–Whitney and chi-square tests.

Results.

The prevalence of anxiety was 10.9% (MAX-PC) and 28.3% (MAX-PC-PSA).

The HADS-A questionnaire indicated pathology in 14.1% of the patients and 16.05% of the spouses.

Depression was detected in 7% (HADS-D) and 9.2% (PHQ-9) of patients as well as in 8.8% (HADS-D) and 16.05% (PHQ-9) of their spouses.

The greatest concordance between men and women was with the PHQ-9 (Spearman’s rho: 0.78; p=0.01).

Education level is significantly related to the presence of anxiety and depression, regardless of the questionnaire applied.

The probability of detecting pathology in the MAX-PC varied from 6% in patients with elementary education to 23.5% in university students ( p=0.04).

The greatest differences were detected when applying the PHQ-9 to patients (4% pathological, elementary education vs.

35.3% pathological, university education).

Our study confirms the lack of a relationship between rates of anxiety and depression and factors such as PSA level, age of the patient and number of comorbidities.

Conclusion.

There is a high prevalence of unsuspected anxiety and depression in patients with prostate cancer and their wives.

Education level correlates with such prevalence.

American Psychological Association (APA)

Sánchez Sánchez, Ernesto& González Baena, Antonio Carlos& González Cáliz, Carlos& Caballero Paredes, Fernando& Moyano Calvo, José Luis& Castiñeiras Fernández, Jesús. 2020. Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality. Prostate Cancer،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1206331

Modern Language Association (MLA)

Sánchez Sánchez, Ernesto…[et al.]. Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality. Prostate Cancer No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1206331

American Medical Association (AMA)

Sánchez Sánchez, Ernesto& González Baena, Antonio Carlos& González Cáliz, Carlos& Caballero Paredes, Fernando& Moyano Calvo, José Luis& Castiñeiras Fernández, Jesús. Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality. Prostate Cancer. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1206331

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1206331